SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-002083
Filing Date
2024-01-11
Accepted
2024-01-11 16:40:23
Documents
15
Period of Report
2024-01-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46963
2 ex99-1.htm EX-99.1 12691
3 ex99-1_001.jpg GRAPHIC 3633
  Complete submission text file 0001493152-24-002083.txt   296735

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bfri-20240111.xsd EX-101.SCH 3967
5 XBRL DEFINITION FILE bfri-20240111_def.xml EX-101.DEF 27426
6 XBRL LABEL FILE bfri-20240111_lab.xml EX-101.LAB 37912
7 XBRL PRESENTATION FILE bfri-20240111_pre.xml EX-101.PRE 26043
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6232
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 24529642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)